Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 147

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 147
---
ented know -howand continuing technological innovation, in particular since OmnigenicsAI has not filed any patent applications in any jurisdiction. We have or may acquire in the future know -howrights pertaining to sample type, sample preparation and processing, sample preservation, bioinformatic processing, biomarkers, gene expression and sequencing technology, data analysis through algorithms, and related methods and formulations. Our success will depend upon our ability to develop proprietary methods and databases and to defend any advantages afforded to us by such methods and databases relative to our competitors. If we do not protect our intellectual property adequately, competitors may be able to use our methods and databases and thereby erode any competitive advantages we may have. 53 We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary technologies are covered by valid and enforceable patents or are effectively maintained as trade secrets. In this regard, in the future, we may apply for patents covering such aspects of our technologies as we deem appropriate. However, we expect that potential patent coverage we may obtain will not be sufficient to prevent substantial competition. In this regard, we believe it is probable that others will independently develop similar or alternative technologies or design around those technologies for which we may obtain patent protection. In addition, any patent applications we file may be challenged and may not result in issued patents or may be invalidated or narrowed in scope after they are issued. Questions as to inventorship or ownership may also arise. Any finding that our patents or applications are unenforceable could harm our ability to prevent others from practicing the related technology, and a finding that others have inventorship or ownership rights to our patents and applications could require us to obtain certain rights to practice related technologies, which may not be available on favorable terms, if at all. If we initiate lawsuits to protect or enforce our patents, or litigate against third -partyclaims, which would be expensive, and, if we lose, we may lose some of our intellectual property rights. Furthermore, these lawsuits may divert the attention of our management and technical personnel. We expect to rely primarily upon trade secrets and proprietary know -howprotection for our confidential and proprietary information, and we may take security measures to protect this information. These measures, however, may not provide adequate protection for our trade secrets, know -howor other confidential information. Among other things, we seek to protect our trade secrets and confidential information by entering into confidentiality agreements with employees and consultants. There can be no assurance that any confidentiality agreements that we have with